Amniotic membrane (AM), also known as amnion, is a thin inner layer of the fetal placenta which surrounds the baby during pregnancy.
Amniotic membrane (AM), also known as amnion, is a thin inner layer of the fetal placenta which surrounds the baby during pregnancy. The AM is filled by amniotic liquid that works as a barrier between the mother’s immune system and the developing baby. The mother’s body would not be able to hold the baby without this barrier.
Owing to numerous advantages such as restoring the epidermal function & integrating itself into the process of healing, amniotic membrane has gained the interest of doctors and other healthcare experts. Amniotic membranes are now used in the treatment for difficult cases of dry eye diseases. It is placed directly on the front of the eye in order to provide a nourishing & protective barrier that can facilitate corneal health and prevent future corneal damage due to dryness.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/4559
Amniotic membrane is the innermost layer forming the fetal membranes. It is used as a graft or as a dressing in different surgical subspecialties. In the field of ophthalmology, this tissue is used as a tissue bandage for cornea infections and sterile melts, and to reconstruct the ocular surface for various procedures. In addition, this membrane protects and stimulates the repair of injured tissues via paracrine actions and also acts as a vector for bio-delivery of exogenous factors to treat injury and ailments. Also, the anti-inflammatory property of transplanted amniotic membrane is used as therapy against chronic inflammation in geriatric population. In addition, amniotic membrane is increasingly used for ocular surface reconstruction, including the treatment of persistent epithelial defects and non-healing corneal ulcers, corneal perforations and descemetoceles, bullous keratopathy, a corneal disorders with associated limbal stem cell deficiency.
Increase in the rapid expansion of the geriatric population along with rise in adoption of amniotic membrane for varied applications fuel the growth of the global amniotic membrane market
According to a report published by Allied Market Research, the global amniotic membrane market size is anticipated to reach $1.7 billion with a considerable CAGR from 2021 to 2030. North America is currently dominating with the highest market share and is expected to manifest the quickest growth rate. This is attributed to advanced healthcare system, rise in R&D activities, increase in substantial research funds, rise in government initiatives regarding amniotic membrane transplantation, and surge in adoption of amniotic membrane for various applications.
However, the outbreak of the COVID-19 pandemic led to have a negative impact on the growth of the global amniotic membrane market. The implantation of global lockdown resulted to cancel or delay elective surgeries. This is because almost all hospitals were focused towards the COVID-19 patient care. Also, in order to maintain the social distancing norms, the number of patients for hospitals visits or clinic visits decreased to a significant level, which in turn, hampered the growth of the market to some extent. Nevertheless, COVID-19 cases have decreased now and market is recovering with a steady pace. With the growth in technological advancements to innovate cost-effective therapies the global amniotic membrane is expected to gather huge growth in the years to come.